# EUROpean Coronary microCirculatory Resistance and Absolute Flow Trial

> **NCT04598308** · — · UNKNOWN · sponsor: **Catharina Ziekenhuis Eindhoven** · enrollment: 200 (estimated)

## Conditions studied

- Microvascular Angina
- Microvascular Coronary Artery Disease
- Coronary Vasospasm
- Microvascular Resistance

## Interventions

- **DIAGNOSTIC_TEST:** absolute flow and resistance measurements

## Key facts

- **NCT ID:** NCT04598308
- **Lead sponsor:** Catharina Ziekenhuis Eindhoven
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-01
- **Primary completion:** 2022-10-01
- **Final completion:** 2023-10-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2020-10-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04598308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04598308, "EUROpean Coronary microCirculatory Resistance and Absolute Flow Trial". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04598308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*